Request Submitted to the Japan Pharmaceutical Association Regarding Considerations in Medication Guidance for Olaparib

On August 5, 2019, ISPACOS visited the Japan Pharmaceutical Association and submitted a request titled “Considerations in Medication Guidance for Olaparib.”

In this request, ISPACOS asked that pharmacists in community pharmacies provide medication guidance for Olaparib with appropriate consideration for patients and ensure that patient-centered counseling is consistently practiced.